FDA.reportPublic FDA data

Complement component C1q IVD, antibody

Definition
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of complement cascade component C1q in a clinical specimen.
GUDID devices
20
Last updated
2025-03-05 15:16:59

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
B502BSB300110C1q / FITC RPabBIO SB, INC.Concentrate, 1 ml 2020-03-16
04015630971473FITC Anti -C1Q Primary AntibodyVentana Medical Systems, Inc.052679940012021-01-29
05700572034698Poly Rb A-Hu C1q ComplementAGILENT TECHNOLOGIES SINGAPORE PTE LTDA01362020-09-17
B502BSB3001050C1q / FITCBIO SB, INC.Concentrate, 0.5 ml2020-06-15
B502BSB3001150Tinto C1q / FITCBIO SB, INC.Predilute, 15 ml2020-06-15
B502BSB300130Tinto C1q / FITCBIO SB, INC.Predilute, 3 ml2020-06-15
B502BSB300170Tinto C1q / FITCBIO SB, INC.Predilute, 7 ml2020-06-15
B502BSB30190Tinto C1q, RPabBIO SB, INC.Predilute, 3 ml 2020-06-15
B502BSB30200Tinto C1q, RPabBIO SB, INC.Predilute, 7 ml2020-06-15
B502BSB30210Tinto C1q, RPabBIO SB, INC.Predilute, 15 ml 2020-06-15
B502BSB30220C1q, RPabBIO SB, INC.Concentrate, 0.1 ml2020-06-15
B502BSB30230C1q, RPabBIO SB, INC.Concentrate, 0.5 ml.2020-06-15
B502BSB30240C1q, RPabBIO SB, INC.Concentrate, 1 ml 2020-06-15
L502BSB30011C1q / FITC RPabBIO SB, INC.Concentrate, 1 ml 2020-03-16
L502BSB3001C1q / FITC RPabBIO SB, INC.Concentrate, 1 ml 2020-03-16
B1761110Antiserum to Human C1qKENT LABORATORIES INC12016-09-24
B1761112Anti Human Complement C1q FITCKENT LABORATORIES INC12016-09-24
B1761114C1q RID plate packageKENT LABORATORIES INC12016-09-24
B1761115C1q RID plate packageKENT LABORATORIES INC12016-09-24
05051700010511Human Complement C1q BINDARID™ Radial Immunodiffusion KitTHE BINDING SITE GROUP LIMITEDRN020.32016-09-24